Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial using health care databases
GLP-1 medications work through two primary mechanisms within the brain: Strengthening the blood-brain barrier, which protects against harmful substances 28 Reducing neuroinflammation through specialized brain cells called microglia and astrocytes 29 GLP-1 receptor signaling enhances neuron growth and survival 28
Understand what you are taking: Ask whether the medication is FDA-approved or compounded
Driven by the new drug approvals (for different applications), and extensive R&D efforts of the companies (to enhance delivery mechanisms of GLP-1 drugs), the market is anticipated to witness steady growth in the coming decade
[23] There is also a potential risk of medullary thyroid carcinoma associated with the use of the drug
Do not expect results overnight